Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are there specific stretches to avoid while on lipitor?What's the recommended schedule for lurbinectedin side effect checks?Can turmeric enhance lipitor's efficacy or side effects?Antiox mebendazole price?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for sivextro
Sivextro (tedizolid phosphate) treats acute bacterial skin and skin structure infections (ABSSSI) in adults and children aged 12+ weighing at least 40 kg. The standard regimen is 200 mg taken orally or by IV infusion once daily for 6 days.[1][2] Patients complete the full 6-day course, even if symptoms improve earlier, to clear the infection fully. For pediatric patients under 40 kg, dosing adjusts by weight (4 mg/kg once daily, max 200 mg), but duration remains 6 days.[2]
Unlike vancomycin, which often requires 7-14 days of twice-daily IV dosing for ABSSSI, Sivextro's shorter 6-day once-daily schedule improves patient convenience and adherence. Both target gram-positive bacteria like MRSA, but Sivextro has better oral bioavailability.[1][3]
Consult a doctor if symptoms persist or worsen after completing the course. Extended treatment beyond 6 days isn't standard and risks side effects like nausea, diarrhea, or rare liver issues. Culture tests guide any changes.[2][4]
Avoid in patients with hypersensitivity to tedizolid. No dose adjustment for mild-moderate kidney or liver impairment, but monitor closely in severe cases. It's not approved for kids under 12 or non-ABSSSI infections.[1][2] [1]: Sivextro Prescribing Information (FDA) [2]: Drugs.com - Sivextro Dosage [3]: IDSA Guidelines for Skin Infections [4]: Medscape - Tedizolid Dosing
Other Questions About Sivextro :